Delta Air Lines Inc said Wednesday it intends to buy up to an additional 32 percent of Grupo Aeromexico, in what could be a nearly $600 million cash deal that strengthens its grip on a fast-growing market.
The investment could raise Delta’s 4.1-percent stake in Aeromexico to 49 percent, if Delta and its pension trust also exercise share purchase options they hold. Delta offered to pay some 52 percent above the Mexican airline’s closing price of 28.74 Mexican pesos.
The move reflects an attempt by Delta to raise competition with American Airlines Group Inc, which has been a larger player in travel to Latin America. It follows a recent application by Delta and Aeromexico for immunity from U.S. antitrust law so they can coordinate schedules and prices for flights, making connections more attractive for customers.
Aeromexico said in a news release that it was informed of Delta’s intentions. The deal remains subject to approval by both companies’ boards.
“This new investment demonstrates Delta’s confidence in Mexico’s future,” Delta’s President Ed Bastian, who sits on Aeromexico’s board, said in a news release.
Full content: Bloomberg
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas